| Financial Year |
March 31 2023 |
| Monetary Funds |
6,735,561,337.16 |
| Held-for-trading Financial Assets |
3,273,203,199.59 |
| Notes Receivable |
27,665,602.66 |
| Accounts Receivable |
603,313,858.03 |
| Advances to Suppliers |
687,649,669.35 |
| Other Receivables |
2,943,983,483.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,080,583,613.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
762,021,183.37 |
| Total Current Assets |
20,117,893,567.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,388,804,373.21 |
| Investment Properties |
176,988,444.62 |
| Fixed Assetes |
30,625,095,113.56 |
| Under-construction Projects |
7,027,507,894.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,218,517,244.15 |
| R&D expenses |
7,860,622.50 |
| Goodwill |
3,142,234,454.02 |
| Long-Term Deferred and Prepaid Expenses |
31,771,504.40 |
| Deferred Income Tax Assets |
306,826,288.03 |
| Other Non-Current Assets |
5,813,270,180.44 |
| Sub-Total of Non-Current Assets |
73,878,273,522.32 |
| Total Assets |
93,996,167,089.42 |
| Short-Term Loans |
11,169,218,506.26 |
| Trading Financial liabilities |
8,025,459,150.53 |
| Notes Payable |
3,101,875,352.56 |
| Accounts Payable |
4,025,597,542.93 |
| Accounts Received In Advance |
2,528,145.95 |
| Employee Compensation Payable |
391,699,654.49 |
| Taxes Payable |
418,696,188.71 |
| Interest Payable |
-- |
| Dividend Payable |
231,667,486.43 |
| Other payables |
5,280,124,552.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
548,434,783.54 |
| Other Current Liabilities |
2,029,800,974.80 |
| Sub-Total of Current Liabilities |
35,431,320,989.83 |
| Long-term Loans |
15,623,075,077.84 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,092,469,912.72 |
| Special Payable |
-- |
| Estimatied Liabilities |
845,881,352.50 |
| Deferred Income Tax Liabilities |
3,683,093,998.49 |
| Other Non-Current Liabilities |
36,295,569.00 |
| Sub-Total of Non-Current Liabilities |
21,456,373,253.12 |
| Total Liabilities |
56,887,694,242.95 |
| Paid-In Capital(Or Share Stock) |
4,473,429,525.00 |
| Capital Surplus |
4,374,902,267.20 |
| Surplus Reserve |
1,055,026,802.03 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
13,244,532,676.56 |
| Minority Stockholder's Interest |
3,899,794,406.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
33,208,678,440.34 |
| Owner's Equity（Stockholder's Equity） |
37,108,472,846.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
93,996,167,089.42 |
